<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vision (Basel)</journal-id><journal-id journal-id-type="iso-abbrev">Vision (Basel)</journal-id><journal-id journal-id-type="publisher-id">vision</journal-id><journal-title-group><journal-title>Vision</journal-title></journal-title-group><issn pub-type="epub">2411-5150</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40407624</article-id><article-id pub-id-type="pmc">PMC12101209</article-id>
<article-id pub-id-type="doi">10.3390/vision9020042</article-id><article-id pub-id-type="publisher-id">vision-09-00042</article-id><article-categories><subj-group subj-group-type="heading"><subject>Systematic Review</subject></subj-group></article-categories><title-group><article-title>Latin American Prevalence of Glaucoma: A Systematic Review and Meta-Analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0008-2540-3240</contrib-id><name><surname>Mora-Paez</surname><given-names>Denisse J.</given-names></name><xref rid="af1-vision-09-00042" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8174-8082</contrib-id><name><surname>Guedes</surname><given-names>Jaime</given-names></name><xref rid="af1-vision-09-00042" ref-type="aff">1</xref><xref rid="c1-vision-09-00042" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0002-7948-154X</contrib-id><name><surname>Amaral</surname><given-names>Dillan Cunha</given-names></name><xref rid="af2-vision-09-00042" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name><surname>Ferreira</surname><given-names>Marcelo Alves</given-names></name><xref rid="af3-vision-09-00042" ref-type="aff">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-5385-3571</contrib-id><name><surname>Fernandes</surname><given-names>Bruno F.</given-names></name><xref rid="af4-vision-09-00042" ref-type="aff">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0000-1012-2341</contrib-id><name><surname>Pereira</surname><given-names>Sacha F.</given-names></name><xref rid="af5-vision-09-00042" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><name><surname>Botton</surname><given-names>Bruno</given-names></name><xref rid="af6-vision-09-00042" ref-type="aff">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0006-2786-7116</contrib-id><name><surname>Desai</surname><given-names>Alisha</given-names></name><xref rid="af1-vision-09-00042" ref-type="aff">1</xref><xref rid="af7-vision-09-00042" ref-type="aff">7</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4569-116X</contrib-id><name><surname>Pakter</surname><given-names>Helena Messinger</given-names></name><xref rid="af8-vision-09-00042" ref-type="aff">8</xref><xref rid="af9-vision-09-00042" ref-type="aff">9</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6925-1794</contrib-id><name><surname>Lavinsky</surname><given-names>Fabio</given-names></name><xref rid="af1-vision-09-00042" ref-type="aff">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0007-9297-9111</contrib-id><name><surname>Filho</surname><given-names>Adroaldo Alencar Costa</given-names></name><xref rid="af2-vision-09-00042" ref-type="aff">2</xref></contrib></contrib-group><aff id="af1-vision-09-00042"><label>1</label>Glaucoma Research Center, Wills Eye Hospital, Philadelphia, PA 19107, USA; <email>dpaez@willseye.org</email> (D.J.M.-P.); <email>alisha.desai@students.jefferson.edu</email> (A.D.); <email>ylavinsky@hotmail.com</email> (F.L.)</aff><aff id="af2-vision-09-00042"><label>2</label>Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro 21941-971, RJ, Brazil; <email>dillanamaral@ufrj.br</email> (D.C.A.); <email>adroaldoalencar@hotmail.com</email> (A.A.C.F.)</aff><aff id="af3-vision-09-00042"><label>3</label>Department of Statistics, S&#x000e3;o Paulo University, S&#x000e3;o Paulo 05403-000, SP, Brazil; <email>analistaestatistico@gmail.com</email></aff><aff id="af4-vision-09-00042"><label>4</label>Argumento Institute, Montreal, QC J4B 2G6, Canada; <email>bruno.mtl@gmail.com</email></aff><aff id="af5-vision-09-00042"><label>5</label>Faculty of Medical Sciences of Paraiba, FCM, AFYA, Jo&#x000e3;o Pessoa 58106-402, PB, Brazil; <email>sachafernandesp@gmail.com</email></aff><aff id="af6-vision-09-00042"><label>6</label>Cl&#x000ed;nica Schmitt Botton, Santa Maria 97060-360, RS, Brazil; <email>brunobotton@hotmail.com</email></aff><aff id="af7-vision-09-00042"><label>7</label>Sidney Kimmel Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA</aff><aff id="af8-vision-09-00042"><label>8</label>Department of Ophthalmology, Federal University of Rio Grande do Sul, Porto Alegre 90040-060, RS, Brazil; <email>hmpakter@hcpa.edu.br</email></aff><aff id="af9-vision-09-00042"><label>9</label>Department of Ophthalmology, Hospital of Clinics from Porto Alegre, Porto Alegre 90035-903, RS, Brazil</aff><author-notes><corresp id="c1-vision-09-00042"><label>*</label>Correspondence: <email>jaimeguedes@gmail.com</email></corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>5</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>6</month><year>2025</year></pub-date><volume>9</volume><issue>2</issue><elocation-id>42</elocation-id><history><date date-type="received"><day>23</day><month>3</month><year>2025</year></date><date date-type="rev-recd"><day>24</day><month>4</month><year>2025</year></date><date date-type="accepted"><day>25</day><month>4</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>We conducted a systematic review and meta-analysis to estimate the prevalence of all types of glaucoma in Latin America (LATAM) and evaluate potential demographic associations. This study followed PRISMA guidelines and was registered in PROSPERO (CRD42024506330). A comprehensive search of PubMed, SciELO, and Web of Science was conducted to identify population-based or cross-sectional studies reporting glaucoma prevalence in LATAM. Studies were categorized into two groups: Group 1 included general population studies without selection based on visual acuity (VA), and Group 2 included studies limited to individuals with VA &#x0003c; 20/60. Data from five studies in Group 1 (25,288 individuals) and eight studies in Group 2 (29,882 individuals) were analyzed using R software. The pooled prevalence of glaucoma was 4% (95% CI: 1&#x02013;3%) in Group 1 and 1% (95% CI: 0&#x02013;1%) in Group 2. No statistically significant associations were found between glaucoma prevalence and sex (<italic toggle="yes">p</italic> = 0.08) or age (<italic toggle="yes">p</italic> = 0.5669). Although our findings highlight the relevance of glaucoma as a public health concern in LATAM, the limited number of available studies and methodological variability reduce the certainty of the estimates.</p></abstract><kwd-group><kwd>meta-analysis</kwd><kwd>systematic review</kwd><kwd>glaucoma</kwd><kwd>prevalence</kwd><kwd>Latin America</kwd></kwd-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-vision-09-00042"><title>1. Introduction</title><p>Blindness and visual impairment are critical public health issues that affect approximately 596 million people worldwide [<xref rid="B1-vision-09-00042" ref-type="bibr">1</xref>]. As the leading cause of irreversible blindness and the second leading cause of blindness, glaucoma imposes a significant societal burden worldwide [<xref rid="B2-vision-09-00042" ref-type="bibr">2</xref>,<xref rid="B3-vision-09-00042" ref-type="bibr">3</xref>,<xref rid="B4-vision-09-00042" ref-type="bibr">4</xref>]. Glaucoma comprises a diverse group of optic neuropathies characterized by the gradual degeneration of retinal ganglion cells and their axons. This degeneration results in varying degrees of irreversible visual field loss over time [<xref rid="B1-vision-09-00042" ref-type="bibr">1</xref>,<xref rid="B5-vision-09-00042" ref-type="bibr">5</xref>]. In 2020, the number of people with glaucoma worldwide was estimated to be more than 70 million, with a predicted increase to more than 110 million by 2040 [<xref rid="B6-vision-09-00042" ref-type="bibr">6</xref>]. The population-based prevalence of glaucoma varies widely across individual studies due to various risk factors present in samples studied, including age, sex, and geographic location [<xref rid="B6-vision-09-00042" ref-type="bibr">6</xref>,<xref rid="B7-vision-09-00042" ref-type="bibr">7</xref>,<xref rid="B8-vision-09-00042" ref-type="bibr">8</xref>,<xref rid="B9-vision-09-00042" ref-type="bibr">9</xref>].</p><p>Historical epidemiological studies show significantly different results from recent studies due to updated study designs and diagnostic methods [<xref rid="B10-vision-09-00042" ref-type="bibr">10</xref>,<xref rid="B11-vision-09-00042" ref-type="bibr">11</xref>]. According to United Nations data, Latin America (LATAM) accounts for 8.3% of the world&#x02019;s population [<xref rid="B12-vision-09-00042" ref-type="bibr">12</xref>]. Although the prevalence of glaucoma has been estimated globally by meta-analyses of epidemiological population-based studies [<xref rid="B6-vision-09-00042" ref-type="bibr">6</xref>], there are few population-based studies on glaucoma prevalence in the LATAM region. Instead, the estimated prevalence of open-angle glaucoma (OAG) has been calculated using studies conducted on Hispanic populations in the United States [<xref rid="B13-vision-09-00042" ref-type="bibr">13</xref>,<xref rid="B14-vision-09-00042" ref-type="bibr">14</xref>,<xref rid="B15-vision-09-00042" ref-type="bibr">15</xref>]. Since 2000, there have been additional studies on the prevalence of glaucoma in individual LATAM countries [<xref rid="B15-vision-09-00042" ref-type="bibr">15</xref>,<xref rid="B16-vision-09-00042" ref-type="bibr">16</xref>,<xref rid="B17-vision-09-00042" ref-type="bibr">17</xref>]. However, to our knowledge, no meta-analysis covering the prevalence of glaucoma in the LATAM region has been published. Based on the need to establish the impact of glaucoma in LATAM, we carried out this systematic review and meta-analysis to assess the prevalence of glaucoma in LATAM populations.</p></sec><sec id="sec2-vision-09-00042"><title>2. Materials and Methods</title><p>This meta-analysis was performed according to the guidelines of the Declaration Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) and the recommendations of the Cochrane Collaboration [<xref rid="B18-vision-09-00042" ref-type="bibr">18</xref>,<xref rid="B19-vision-09-00042" ref-type="bibr">19</xref>]. The protocol was registered in the International Prospective Register of Systematic Reviews (PROSPERO) under registration number CRD42024506330.</p><sec id="sec2dot1-vision-09-00042"><title>2.1. Elibility Criteria</title><p>Studies that met the following eligibility criteria were included: (1) cohort or cross-sectional studies; (2) population-based studies of any type of glaucoma conducted in LATAM countries; (3) studies with clear definitions of random or clustered sampling procedures; (4) studies including people aged &#x02265; 18 years; and (5) studies from which the prevalence data for glaucoma in an LATAM population could be extracted or calculated. Exclusion criteria were as follows: (1) studies that were not general population-based (e.g., hospital-based or clinical-based); (2) studies that did not include the number of subjects with glaucoma; (3) studies that used data from the authors&#x02019; previous publications.</p></sec><sec id="sec2dot2-vision-09-00042"><title>2.2. Information Source</title><p>Two authors (M.F. and B.F.) independently searched PubMed, Web of Science, and SciELO from inception to January 2024. The references from all included studies were also searched manually for any additional studies that could meet the eligibility criteria. Eventual conflicts were resolved by consensus among the authors.</p></sec><sec id="sec2dot3-vision-09-00042"><title>2.3. Search Strategy</title><p>The following terms were used in our search strategy: &#x0201c;prevalence&#x0201d; and &#x0201c;glaucoma&#x0201d;. Alternative terms for &#x0201c;prevalence&#x0201d; and &#x0201c;survey&#x0201d; were also used. When searching Web of Science, a country/region filter was used, limiting the results to the scope of LATAM. Additional steps and filter strategies used in PubMed and SciELO searches are detailed in <xref rid="app1-vision-09-00042" ref-type="app">Supplementary File S1</xref>. There were no publication date or language restrictions in our electronic search.</p></sec><sec id="sec2dot4-vision-09-00042"><title>2.4. Study Selection</title><p>We imported search results into Zotero software. Duplicate entries were excluded. Two independent authors (D.A. and J.G.) applied the eligibility criteria to screen titles and abstracts. After that, full texts of potentially eligible studies were retrieved. </p></sec><sec id="sec2dot5-vision-09-00042"><title>2.5. Data Extraction</title><p>Two authors (D.A. and J.G.) extracted the following data from selected studies: (1) first author; (2) year of study; (3) mean age of the sample (in years); (4) total sample size; (5) total prevalence of glaucoma; and (6) male and female prevalence. Also, the same authors (D.A. and J.G.) collected pre-specified baseline characteristics and outcome data, and recorded these in an Excel template.</p></sec><sec id="sec2dot6-vision-09-00042"><title>2.6. Endpoints and Subgroup Analysis</title><p>For the prevalence analysis, we divided the studies into two groups. The first group (Group 1) included studies that applied no visual acuity (VA)-based restrictions in their eligibility criteria [<xref rid="B15-vision-09-00042" ref-type="bibr">15</xref>,<xref rid="B16-vision-09-00042" ref-type="bibr">16</xref>,<xref rid="B17-vision-09-00042" ref-type="bibr">17</xref>,<xref rid="B20-vision-09-00042" ref-type="bibr">20</xref>,<xref rid="B21-vision-09-00042" ref-type="bibr">21</xref>], while the second group (Group 2) comprised studies that selected participants exclusively based on having a VA of less than 20/60 [<xref rid="B22-vision-09-00042" ref-type="bibr">22</xref>,<xref rid="B23-vision-09-00042" ref-type="bibr">23</xref>,<xref rid="B24-vision-09-00042" ref-type="bibr">24</xref>,<xref rid="B25-vision-09-00042" ref-type="bibr">25</xref>,<xref rid="B26-vision-09-00042" ref-type="bibr">26</xref>,<xref rid="B27-vision-09-00042" ref-type="bibr">27</xref>,<xref rid="B28-vision-09-00042" ref-type="bibr">28</xref>]. This division was not only based on our methodological considerations but also reflected the categorization explicitly or implicitly adopted by the original studies themselves. We separated the studies in this manner because Group 2 consisted primarily of blindness surveys targeting individuals with visual impairment, which are inherently not representative of the general population. Analyzing these studies separately allowed us to avoid underestimating the overall glaucoma prevalence that could occur if fundamentally different sampling methods were pooled together.</p><p>The outcomes of interest include (1) the overall prevalence of glaucoma in the LATAM population, and in male and female subgroups using the studies of Group 1; and (2) the prevalence of glaucoma among individuals with moderate vision impairment (MVI) (VA &#x0003c; 20/60 and &#x02265;20/200), severe vision impairment (SVI) (VA &#x0003c; 20/200 and &#x02265;20/400), and blindness (VA &#x0003c; 20/400) using the studies of Group 2.</p></sec><sec id="sec2dot7-vision-09-00042"><title>2.7. Statistical Analysis and Risk of Bias Assessment</title><p>We selected the prevalence of glaucoma in the LATAM population as the primary outcome. All statistical analyses were done using R software, version 4.3.1. The &#x0201c;meta&#x0201d; package was utilized to generate forest plots illustrating the prevalence of glaucoma in LATAM across individual studies, including their respective weights and the pooled prevalence with associated 95% confidence intervals (CI). Heterogeneity between studies was quantified using I<sup>2</sup> statistic [<xref rid="B29-vision-09-00042" ref-type="bibr">29</xref>]. I<sup>2</sup> values &#x0003e; 50% were considered to indicate significance for heterogeneity [<xref rid="B30-vision-09-00042" ref-type="bibr">30</xref>]. A funnel plot was used to assess potential bias and minor/significant study effects [<xref rid="B31-vision-09-00042" ref-type="bibr">31</xref>]. Asymmetry was evaluated using Begg&#x02019;s test [<xref rid="B32-vision-09-00042" ref-type="bibr">32</xref>]. A meta-regression model was employed to examine the potential variation in glaucoma prevalence with age using the mean age reported in included studies [<xref rid="B33-vision-09-00042" ref-type="bibr">33</xref>]. However, this analysis was limited by the availability of mean age data in only six studies. The quality of each selected article was assessed using the checklist developed by Downs and Black, and each included article was assessed and scored on a 10-item scale [<xref rid="B34-vision-09-00042" ref-type="bibr">34</xref>]. The prevalence of glaucoma in LATAM was estimated using the &#x0201c;random effects&#x0201d; calculation method. The original proportions were transformed into &#x0201c;logit&#x0201d; values (log(p/(1 &#x02212; p))), and the weights were calculated based on the inverse of the variance of proportions.</p></sec></sec><sec sec-type="results" id="sec3-vision-09-00042"><title>3. Results</title><sec id="sec3dot1-vision-09-00042"><title>3.1. Study Selection and Baseline Characteristics</title><p>An initial search identified 404 potential articles, and 13 studies remained after removing duplicate records and studies that did not meet the eligibility criteria (<xref rid="vision-09-00042-f001" ref-type="fig">Figure 1</xref>).</p><p>Among these 13 studies, five were in Group 1 [<xref rid="B15-vision-09-00042" ref-type="bibr">15</xref>,<xref rid="B16-vision-09-00042" ref-type="bibr">16</xref>,<xref rid="B17-vision-09-00042" ref-type="bibr">17</xref>,<xref rid="B20-vision-09-00042" ref-type="bibr">20</xref>,<xref rid="B21-vision-09-00042" ref-type="bibr">21</xref>] with a total of 25,288 individuals, and eight in Group 2 [<xref rid="B22-vision-09-00042" ref-type="bibr">22</xref>,<xref rid="B23-vision-09-00042" ref-type="bibr">23</xref>,<xref rid="B24-vision-09-00042" ref-type="bibr">24</xref>,<xref rid="B25-vision-09-00042" ref-type="bibr">25</xref>,<xref rid="B26-vision-09-00042" ref-type="bibr">26</xref>,<xref rid="B27-vision-09-00042" ref-type="bibr">27</xref>,<xref rid="B28-vision-09-00042" ref-type="bibr">28</xref>] with 29,882 individuals. The subject count ranged from 1261 (Mitchell, 2008 [<xref rid="B21-vision-09-00042" ref-type="bibr">21</xref>]) to 18,892 (Castellanos-Perrilla, 2015 [<xref rid="B16-vision-09-00042" ref-type="bibr">16</xref>]); combined, a total of 55,170 subjects were analyzed [<xref rid="B16-vision-09-00042" ref-type="bibr">16</xref>,<xref rid="B21-vision-09-00042" ref-type="bibr">21</xref>]. The characteristics and quality assessment scores (maximum of 10) of the included studies are indicated in <xref rid="vision-09-00042-t001" ref-type="table">Table 1</xref>.</p></sec><sec id="sec3dot2-vision-09-00042"><title>3.2. Pooled Analysis</title><sec id="sec3dot2dot1-vision-09-00042"><title>3.2.1. Prevalence of Glaucoma in the LATAM Population</title><p>The analysis of all glaucoma cases in Group 1 showed a prevalence of 4% (95% CI: 1 to 12%; I<sup>2</sup>: 96%; <xref rid="vision-09-00042-f002" ref-type="fig">Figure 2</xref>) while in Group 2, the prevalence was 1% (95% CI: 0 to 1%; I<sup>2</sup>: 78%; <xref rid="vision-09-00042-f003" ref-type="fig">Figure 3</xref>). The meta-regression model did not reveal a significant association between age and prevalence (<italic toggle="yes">p</italic> = 0.56).</p></sec><sec id="sec3dot2dot2-vision-09-00042"><title>3.2.2. Subgroup Analysis</title><p>We observed methodological heterogeneity between studies by subgroup, where I<sup>2</sup> = 92% and I<sup>2</sup> = 94% for female and male subgroups, respectively. The analysis of the prevalence of glaucoma in LATAM based on sex was reported in all studies of Group 1. The pooled analysis showed a prevalence of 4% (95 CI: 1 to 13%) in females and 4% (95 CI: 2 to 8%) in males with a random-effect model (<xref rid="vision-09-00042-f004" ref-type="fig">Figure 4</xref>). There was no statistically significant difference based on sex (<italic toggle="yes">p</italic> = 0.8).</p><p>The pooled prevalence of glaucoma in the LATAM population with MVI was 3% (95% CI: 2 to 4%), while the pooled prevalence was 7% (95% CI: 3 to 13%) in the population with SVI (<xref rid="vision-09-00042-f005" ref-type="fig">Figure 5</xref> and <xref rid="vision-09-00042-f006" ref-type="fig">Figure 6</xref>, respectively) and 10% (95% CI, 5 to 19%) in the blindness population (<xref rid="vision-09-00042-f007" ref-type="fig">Figure 7</xref>).</p></sec></sec><sec id="sec3dot3-vision-09-00042"><title>3.3. Quality and Evidence Assessment and Risk of Bias</title><p>All the studies included in our analysis were cross-sectional or population based. Of these, three studies scored a 10 in quality assessment, five studies scored a 9, and five studies received a score of 8. The funnel plot and Begg&#x02019;s test for asymmetry showed homogeneity (z = &#x02212;1.59; <italic toggle="yes">p</italic> = 0.11), indicating that any potentially biased outliers did not significantly affect estimates (<xref rid="vision-09-00042-f008" ref-type="fig">Figure 8</xref>).</p></sec></sec><sec sec-type="discussion" id="sec4-vision-09-00042"><title>4. Discussion</title><p>Based on this meta-analysis of 13 population-based studies, which comprised a total of 55,170 subjects, the overall prevalence of glaucoma in the LATAM population in Group 1 was 4% (95% CI: 1 to 12%), and in Group 2 was 1% (95% CI: 0.00 to 0.01%).</p><p>This estimation of 4% in Group 1 is similar to the previous report of 3.4% LATAM and Caribbean primary open-angle glaucoma (POAG) prevalence in 2021 and previous systematic review and meta-analysis results of 3.90% LATAM and Caribbean prevalence of POAG in 2021 [<xref rid="B6-vision-09-00042" ref-type="bibr">6</xref>,<xref rid="B35-vision-09-00042" ref-type="bibr">35</xref>]. Both reviews were based on studies that did not use impairment evaluation for selecting participants. As a result, the subgroup analyses, which similarly lacked impairment evaluation, yielded comparable results. However, in Group 2, the reported prevalence of low vision was 1%. This discrepancy suggests that focusing solely on patients with VA &#x0003c; 20/60 may underestimate the overall prevalence of glaucoma.</p><p>Previous reports suggest that the role of sex as a potential risk factor for glaucoma remains controversial [<xref rid="B7-vision-09-00042" ref-type="bibr">7</xref>,<xref rid="B36-vision-09-00042" ref-type="bibr">36</xref>,<xref rid="B37-vision-09-00042" ref-type="bibr">37</xref>,<xref rid="B38-vision-09-00042" ref-type="bibr">38</xref>,<xref rid="B39-vision-09-00042" ref-type="bibr">39</xref>,<xref rid="B40-vision-09-00042" ref-type="bibr">40</xref>,<xref rid="B41-vision-09-00042" ref-type="bibr">41</xref>,<xref rid="B42-vision-09-00042" ref-type="bibr">42</xref>,<xref rid="B43-vision-09-00042" ref-type="bibr">43</xref>]. Previous studies have identified male sex as a potential risk factor for glaucoma, citing males&#x02019; longer axial length and deeper anterior chamber depth as contributing factors [<xref rid="B44-vision-09-00042" ref-type="bibr">44</xref>,<xref rid="B45-vision-09-00042" ref-type="bibr">45</xref>,<xref rid="B46-vision-09-00042" ref-type="bibr">46</xref>]. However, additional studies have identified female sex as a potential risk factor for glaucoma [<xref rid="B40-vision-09-00042" ref-type="bibr">40</xref>,<xref rid="B43-vision-09-00042" ref-type="bibr">43</xref>,<xref rid="B47-vision-09-00042" ref-type="bibr">47</xref>], suggesting that anatomical predispositions and fluctuations in female sex hormones could influence IOP and vascular resistance, thereby potentially impacting optic nerve head circulation [<xref rid="B37-vision-09-00042" ref-type="bibr">37</xref>]. In our study, the difference between sexes was not a significant risk factor for glaucoma (<italic toggle="yes">p</italic> = 0.8). Thus, the impact of sex on glaucoma is still inconclusive [<xref rid="B11-vision-09-00042" ref-type="bibr">11</xref>,<xref rid="B37-vision-09-00042" ref-type="bibr">37</xref>]. With the global population aging, and the prevalence of glaucoma and glaucoma-related blindness on the rise, there is a growing need to conduct further, more extensive studies on this topic with the overall goal of raising awareness and enhancing our understanding of sex disparities in glaucoma health. Such efforts will also aid in identifying at-risk populations and optimizing resource allocation in order to improve care for patients with glaucoma.</p><p>To estimate the prevalence of blindness and visual impairment in Group 2, eight studies were examined. The prevalence of blindness found in Uruguay is the lowest for all Rapid Assessment of Avoidable Blindness (RAAB) studies performed in Latin America thus far [<xref rid="B24-vision-09-00042" ref-type="bibr">24</xref>]. The significant occurrence of blindness caused by glaucoma underscores the need for early detection to halt disease progression. The analysis of the prevalence of MVI, SVI, and blindness resulted in the assessment of 2738, 570, and 933 subjects, respectively. Thus, in Group 2, the pooled prevalence of MVI due to glaucoma was 3% (95% CI: 2 to 4%), while SVI was 7% (95% CI: 3 to 13), and blindness was 10% (95% CI, 5 to 19%). This analysis shows that the prevalence of glaucoma increases as visual impairment worsens. Patients with MVI due to glaucoma may be unaware of the condition due to subtle or asymptomatic symptoms. As vision deteriorates, the rate of SVI and blindness due to glaucoma increases, possibly due to disease progression without adequate treatment or resistance to interventions, resulting in total vision loss [<xref rid="B48-vision-09-00042" ref-type="bibr">48</xref>,<xref rid="B49-vision-09-00042" ref-type="bibr">49</xref>].</p><p>Although the included studies did not report on specific public health actions or preventive strategies, our findings highlight the need for such measures to be prioritized in LATAM. Given the asymptomatic progression of glaucoma and its high prevalence, we suggest that future regional efforts include widespread screening programs, public awareness campaigns, and improved access to diagnostic and treatment services. Implementing such initiatives could facilitate earlier detection and management, ultimately reducing the burden of glaucoma-related visual impairment in the region. These results are especially relevant for ophthalmologists, public health officials, policymakers, and researchers aiming to understand the regional burden of glaucoma. However, the findings also reveal critical gaps in data standardization, geographic coverage, and reporting of demographic subgroups. Future studies should focus on longitudinal trends, evaluate regional screening and treatment programs, and incorporate detailed demographic and clinical data to support more targeted and effective glaucoma control strategies across LATAM.</p><p>Although the results of this study provide significant insights into the prevalence of glaucoma in LATAM, it is important to consider its limitations. The included studies do not encompass all countries in LATAM, as shown in <xref rid="vision-09-00042-t001" ref-type="table">Table 1</xref>, and they are limited in representing the diverse population characteristics of their countries of origin. For example, the study by Sakata et al. focuses on a South Brazilian population, which, in a vast and diverse country like Brazil, may not fully capture the regional differences present across the country [<xref rid="B15-vision-09-00042" ref-type="bibr">15</xref>]. There was a notable degree of heterogeneity across studies, highlighting substantial inconsistency in the definitions of glaucoma (<xref rid="vision-09-00042-t002" ref-type="table">Table 2</xref>) and study design. Recent studies have increasingly sought to standardize these definitions to improve comparability and support more reliable prevalence estimates across populations [<xref rid="B50-vision-09-00042" ref-type="bibr">50</xref>,<xref rid="B51-vision-09-00042" ref-type="bibr">51</xref>,<xref rid="B52-vision-09-00042" ref-type="bibr">52</xref>]. Although the overall heterogeneity in this meta-analysis was high (I<sup>2</sup> = 99%), it is common for meta-analyses of prevalence studies to have very high heterogeneities, with I<sup>2</sup> values usually over 90% [<xref rid="B53-vision-09-00042" ref-type="bibr">53</xref>,<xref rid="B54-vision-09-00042" ref-type="bibr">54</xref>,<xref rid="B55-vision-09-00042" ref-type="bibr">55</xref>]. The random effects models employed in our analysis aimed to address and mitigate this limitation. Random effects models are preferred over fixed-effect models in medical research because they accommodate varying true effects and address unexplained heterogeneity [<xref rid="B56-vision-09-00042" ref-type="bibr">56</xref>,<xref rid="B57-vision-09-00042" ref-type="bibr">57</xref>,<xref rid="B58-vision-09-00042" ref-type="bibr">58</xref>]. Subgroup analyses by sex were underpowered and did not distinguish between glaucoma subtypes (e.g., POAG vs. primary angle-closure glaucoma [PACG]), limiting the ability to draw meaningful conclusions. This limitation is further compounded by the fact that many included studies lacked detailed subgroup data on variables such as age, race, urban versus rural residence, and specific glaucoma subtypes like PACG, which has been shown in previous reports to have a lower prevalence compared to POAG [<xref rid="B6-vision-09-00042" ref-type="bibr">6</xref>,<xref rid="B58-vision-09-00042" ref-type="bibr">58</xref>]. Moreover, due to LATAM being an ethnically diverse region, the inclusion of various ethnic groups (e.g., Black, White, and Asian) may mask potential differences in glaucoma prevalence among these groups. To address these limitations, we conducted a quality assessment, applied a random effects model and meta-regression, and performed funnel and subgroup analyses.</p><p>Future research should address these gaps through standardized, population-based studies that integrate clinical, demographic, and policy-level data to improve glaucoma surveillance and guide evidence-based healthcare planning in the region.</p></sec><sec sec-type="conclusions" id="sec5-vision-09-00042"><title>5. Conclusions</title><p>In summary, this systematic review and meta-analysis, which included five studies in Group 1 and eight studies in Group 2 encompassing a total of 57,170 subjects, found that the prevalence of glaucoma in LATAM is 4% in Group 1 and 1% in Group 2. As glaucoma remains a worldwide vision-threatening disease with high prevalence, future research is needed to continue to investigate the impact of different variables, such as glaucoma definition, glaucoma type, and sex, on glaucoma prevalence in LATAM. Understanding the differences in glaucoma prevalence between geographical regions worldwide is not only vital for the establishment of public health policies, but will also provide greater insight into the causes behind glaucoma health disparities.</p></sec></body><back><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><app-group><app id="app1-vision-09-00042"><title>Supplementary Materials</title><p>The following supporting information can be downloaded at <uri xlink:href="https://www.mdpi.com/article/10.3390/vision9020042/s1">https://www.mdpi.com/article/10.3390/vision9020042/s1</uri>: Supplemental File S1: Full-search database.</p><supplementary-material id="vision-09-00042-s001" position="float" content-type="local-data"><media xlink:href="vision-09-00042-s001.zip"/></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>Conceptualization, D.J.M.-P. and J.G.; methodology, D.J.M.-P., D.C.A. and M.A.F.; software, D.J.M.-P.; validation, D.J.M.-P., J.G. and D.C.A.; formal analysis, D.J.M.-P. and B.F.F.; investigation, D.J.M.-P., S.F.P. and B.B.; resources, H.M.P. and A.D.; data curation, D.J.M.-P. and A.A.C.F.; writing&#x02014;original draft preparation, D.J.M.-P.; writing&#x02014;review and editing, D.J.M.-P., J.G., F.L. and A.A.C.F.; visualization, D.J.M.-P. and M.A.F.; supervision, J.G. and F.L.; project administration, J.G.; funding acquisition, F.L. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>The original contributions presented in this study are included in the article and <xref rid="app1-vision-09-00042" ref-type="app">Supplementary Material</xref>. Further inquiries can be directed to the corresponding author.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><glossary><title>Abbreviations</title><p>The following abbreviations are used in this manuscript:
<array><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">OAG</td><td align="left" valign="middle" rowspan="1" colspan="1">Open Angle Glaucoma </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">LATAM</td><td align="left" valign="middle" rowspan="1" colspan="1">Latin America</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">PRISMA</td><td align="left" valign="middle" rowspan="1" colspan="1">Preferred Reporting Items for Systematic Reviews and Meta-Analysis </td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CI</td><td align="left" valign="middle" rowspan="1" colspan="1">Confidence Intervals </td></tr></tbody></array></p></glossary><ref-list><title>References</title><ref id="B1-vision-09-00042"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<collab>GBD 2019 Blindness and Vision Impairment Collaborators</collab>
<collab>Vision Loss Expert Group of the Global Burden of Disease Study</collab>
</person-group><article-title>Causes of blindness and vision impairment in 2020 and trends over 30 years, and prevalence of avoidable blindness in relation to VISION 2020: The Right to Sight: An analysis for the Global Burden of Disease Study</article-title><source>Lancet Glob. Health</source><year>2021</year><volume>9</volume><fpage>e144</fpage><lpage>e160</lpage><pub-id pub-id-type="doi">10.1016/S2214-109X(20)30489-7</pub-id><pub-id pub-id-type="pmid">33275949</pub-id>
</element-citation></ref><ref id="B2-vision-09-00042"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Flaxman</surname><given-names>S.R.</given-names></name>
<name><surname>Bourne</surname><given-names>R.R.A.</given-names></name>
<name><surname>Resnikoff</surname><given-names>S.</given-names></name>
<name><surname>Ackland</surname><given-names>P.</given-names></name>
<name><surname>Braithwaite</surname><given-names>T.</given-names></name>
<name><surname>Cicinelli</surname><given-names>M.V.</given-names></name>
<name><surname>Das</surname><given-names>A.</given-names></name>
<name><surname>Jonas</surname><given-names>J.B.</given-names></name>
<name><surname>Keeffe</surname><given-names>J.</given-names></name>
<name><surname>Kempen</surname><given-names>J.H.</given-names></name>
<etal/>
</person-group><article-title>Global causes of blindness and distance vision impairment 1990&#x02013;2020: A systematic review and meta-analysis</article-title><source>Lancet Glob. Health</source><year>2017</year><volume>5</volume><fpage>e1221</fpage><lpage>e1234</lpage><pub-id pub-id-type="doi">10.1016/S2214-109X(17)30393-5</pub-id><pub-id pub-id-type="pmid">29032195</pub-id>
</element-citation></ref><ref id="B3-vision-09-00042"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Quigley</surname><given-names>H.A.</given-names></name>
</person-group><article-title>Glaucoma</article-title><source>Lancet</source><year>2011</year><volume>377</volume><fpage>1367</fpage><lpage>1377</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(10)61423-7</pub-id><pub-id pub-id-type="pmid">21453963</pub-id>
</element-citation></ref><ref id="B4-vision-09-00042"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jonas</surname><given-names>J.B.</given-names></name>
<name><surname>Aung</surname><given-names>T.</given-names></name>
<name><surname>Bourne</surname><given-names>R.R.</given-names></name>
<name><surname>Bron</surname><given-names>A.M.</given-names></name>
<name><surname>Ritch</surname><given-names>R.</given-names></name>
<name><surname>Panda-Jonas</surname><given-names>S.</given-names></name>
</person-group><article-title>Glaucoma</article-title><source>Lancet</source><year>2017</year><volume>390</volume><fpage>2183</fpage><lpage>2193</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(17)31469-1</pub-id><pub-id pub-id-type="pmid">28577860</pub-id>
</element-citation></ref><ref id="B5-vision-09-00042"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weinreb</surname><given-names>R.N.</given-names></name>
<name><surname>Khaw</surname><given-names>P.T.</given-names></name>
</person-group><article-title>Primary open-angle glaucoma</article-title><source>Lancet</source><year>2004</year><volume>363</volume><fpage>1711</fpage><lpage>1720</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(04)16257-0</pub-id><pub-id pub-id-type="pmid">15158634</pub-id>
</element-citation></ref><ref id="B6-vision-09-00042"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Tham</surname><given-names>Y.-C.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Wong</surname><given-names>T.Y.</given-names></name>
<name><surname>Quigley</surname><given-names>H.A.</given-names></name>
<name><surname>Aung</surname><given-names>T.</given-names></name>
<name><surname>Cheng</surname><given-names>C.-Y.</given-names></name>
</person-group><article-title>Global prevalence of glaucoma and projections of glaucoma burden through 2040: A systematic review and meta-analysis</article-title><source>Ophthalmology</source><year>2014</year><volume>121</volume><fpage>2081</fpage><lpage>2090</lpage><pub-id pub-id-type="doi">10.1016/j.ophtha.2014.05.013</pub-id><pub-id pub-id-type="pmid">24974815</pub-id>
</element-citation></ref><ref id="B7-vision-09-00042"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Khachatryan</surname><given-names>N.</given-names></name>
<name><surname>Pistilli</surname><given-names>M.</given-names></name>
<name><surname>Maguire</surname><given-names>M.G.</given-names></name>
<name><surname>Salowe</surname><given-names>R.J.</given-names></name>
<name><surname>Fertig</surname><given-names>R.M.</given-names></name>
<name><surname>Moore</surname><given-names>T.</given-names></name>
<name><surname>Gudiseva</surname><given-names>H.V.</given-names></name>
<name><surname>Chavali</surname><given-names>V.R.M.</given-names></name>
<name><surname>Collins</surname><given-names>D.W.</given-names></name>
<name><surname>Daniel</surname><given-names>E.</given-names></name>
<etal/>
</person-group><article-title>Primary Open-Angle African American Glaucoma Genetics (POAAGG) Study: Gender and risk of POAG in African Americans</article-title><source>PLoS ONE</source><year>2019</year><volume>14</volume><elocation-id>e0218804</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0218804</pub-id><pub-id pub-id-type="pmid">31369581</pub-id>
</element-citation></ref><ref id="B8-vision-09-00042"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vajaranant</surname><given-names>T.S.</given-names></name>
<name><surname>Wu</surname><given-names>S.</given-names></name>
<name><surname>Torres</surname><given-names>M.</given-names></name>
<name><surname>Varma</surname><given-names>R.</given-names></name>
</person-group><article-title>The changing face of primary open-angle glaucoma in the united states: Demographic and geographic changes from 2011 to 2050</article-title><source>Arch. Ophthalmol.</source><year>2012</year><volume>154</volume><fpage>303</fpage><lpage>314.e3</lpage><pub-id pub-id-type="doi">10.1016/j.ajo.2012.02.024</pub-id><pub-id pub-id-type="pmid">22541661</pub-id>
</element-citation></ref><ref id="B9-vision-09-00042"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Friedman</surname><given-names>D.S.</given-names></name>
<name><surname>Foster</surname><given-names>P.J.</given-names></name>
<name><surname>Aung</surname><given-names>T.</given-names></name>
<name><surname>He</surname><given-names>M.</given-names></name>
</person-group><article-title>Angle closure and angle-closure glaucoma: What we are doing now and what we will be doing in the future</article-title><source>Clin. Exp. Ophthalmol.</source><year>2012</year><volume>40</volume><fpage>381</fpage><lpage>387</lpage><pub-id pub-id-type="doi">10.1111/j.1442-9071.2012.02774.x</pub-id><pub-id pub-id-type="pmid">22356460</pub-id>
</element-citation></ref><ref id="B10-vision-09-00042"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chan</surname><given-names>E.W.</given-names></name>
<name><surname>Li</surname><given-names>X.</given-names></name>
<name><surname>Tham</surname><given-names>Y.-C.</given-names></name>
<name><surname>Liao</surname><given-names>J.</given-names></name>
<name><surname>Wong</surname><given-names>T.Y.</given-names></name>
<name><surname>Aung</surname><given-names>T.</given-names></name>
<name><surname>Cheng</surname><given-names>C.-Y.</given-names></name>
</person-group><article-title>Glaucoma in Asia: Regional prevalence variations and future projections</article-title><source>Br. J. Ophthalmol.</source><year>2016</year><volume>100</volume><fpage>78</fpage><lpage>85</lpage><pub-id pub-id-type="doi">10.1136/bjophthalmol-2014-306102</pub-id><pub-id pub-id-type="pmid">26112871</pub-id>
</element-citation></ref><ref id="B11-vision-09-00042"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kapetanakis</surname><given-names>V.V.</given-names></name>
<name><surname>Chan</surname><given-names>M.P.Y.</given-names></name>
<name><surname>Foster</surname><given-names>P.J.</given-names></name>
<name><surname>Cook</surname><given-names>D.G.</given-names></name>
<name><surname>Owen</surname><given-names>C.G.</given-names></name>
<name><surname>Rudnicka</surname><given-names>A.R.</given-names></name>
</person-group><article-title>Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): A systematic review and meta-analysis</article-title><source>Br. J. Ophthalmol.</source><year>2016</year><volume>100</volume><fpage>86</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1136/bjophthalmol-2015-307223</pub-id><pub-id pub-id-type="pmid">26286821</pub-id>
</element-citation></ref><ref id="B12-vision-09-00042"><label>12.</label><element-citation publication-type="webpage"><article-title>United Nations Web Site</article-title><comment>Available online: <ext-link xlink:href="http://esa.un.org" ext-link-type="uri">http://esa.un.org</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-02-15">(accessed on 15 February 2024)</date-in-citation></element-citation></ref><ref id="B13-vision-09-00042"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Varma</surname><given-names>R.</given-names></name>
<name><surname>Ying-Lai</surname><given-names>M.</given-names></name>
<name><surname>A Francis</surname><given-names>B.</given-names></name>
<name><surname>Nguyen</surname><given-names>B.B.-T.</given-names></name>
<name><surname>Deneen</surname><given-names>J.</given-names></name>
<name><surname>Wilson</surname><given-names>M.</given-names></name>
<name><surname>Azen</surname><given-names>S.P.</given-names></name>
<collab>Los Angeles Latino Eye Study Group</collab>
</person-group><article-title>Prevalence of open-angle glaucoma and ocular hypertension in Latinos: The Los Angeles Latino Eye Study</article-title><source>Ophthalmology</source><year>2004</year><volume>111</volume><fpage>1439</fpage><lpage>1448</lpage><pub-id pub-id-type="doi">10.1016/j.ophtha.2004.01.025</pub-id><pub-id pub-id-type="pmid">15288969</pub-id>
</element-citation></ref><ref id="B14-vision-09-00042"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Quigley</surname><given-names>H.A.</given-names></name>
<name><surname>West</surname><given-names>S.K.</given-names></name>
<name><surname>Rodriguez</surname><given-names>J.</given-names></name>
<name><surname>Munoz</surname><given-names>B.</given-names></name>
<name><surname>Klein</surname><given-names>R.</given-names></name>
<name><surname>Snyder</surname><given-names>R.</given-names></name>
</person-group><article-title>The prevalence of glaucoma in a population-based study of hispanic subjects: Proyecto VER</article-title><source>Arch. Ophthalmol.</source><year>2001</year><volume>119</volume><fpage>1819</fpage><lpage>1826</lpage><pub-id pub-id-type="doi">10.1001/archopht.119.12.1819</pub-id><pub-id pub-id-type="pmid">11735794</pub-id>
</element-citation></ref><ref id="B15-vision-09-00042"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sakata</surname><given-names>K.</given-names></name>
<name><surname>Sakata</surname><given-names>L.M.</given-names></name>
<name><surname>Sakata</surname><given-names>V.M.</given-names></name>
<name><surname>Santini</surname><given-names>C.</given-names></name>
<name><surname>Hopker</surname><given-names>L.M.</given-names></name>
<name><surname>Bernardes</surname><given-names>R.</given-names></name>
<name><surname>Yabumoto</surname><given-names>C.</given-names></name>
<name><surname>Moreira</surname><given-names>A.T.R.</given-names></name>
</person-group><article-title>Prevalence of glaucoma in a south brazilian population: Projeto Glaucoma</article-title><source>Investig. Opthalmol. Vis. Sci.</source><year>2007</year><volume>48</volume><fpage>4974</fpage><lpage>4979</lpage><pub-id pub-id-type="doi">10.1167/iovs.07-0342</pub-id><pub-id pub-id-type="pmid">17962447</pub-id>
</element-citation></ref><ref id="B16-vision-09-00042"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Castellanos-Perilla</surname><given-names>N.</given-names></name>
<name><surname>Garcia-Cifuentes</surname><given-names>E.</given-names></name>
<name><surname>Pineda-Ortega</surname><given-names>J.</given-names></name>
<name><surname>Lema</surname><given-names>S.</given-names></name>
<name><surname>Gelvis</surname><given-names>G.</given-names></name>
<name><surname>Cano-Gutierrez</surname><given-names>C.A.</given-names></name>
<name><surname>Mejia-Vergara</surname><given-names>A.J.</given-names></name>
</person-group><article-title>Self-reported glaucoma prevalence and related factors, contribution to reported visual impairment, and functional burden in a cross-sectional study in Colombia</article-title><source>Int. Ophthalmol.</source><year>2023</year><volume>43</volume><fpage>2447</fpage><lpage>2455</lpage><pub-id pub-id-type="doi">10.1007/s10792-023-02643-z</pub-id><pub-id pub-id-type="pmid">36864123</pub-id>
</element-citation></ref><ref id="B17-vision-09-00042"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fernandes</surname><given-names>A.G.</given-names></name>
<name><surname>Berezovsky</surname><given-names>A.</given-names></name>
<name><surname>Watanabe</surname><given-names>S.E.S.</given-names></name>
<name><surname>Mitsuhiro</surname><given-names>M.R.K.H.</given-names></name>
<name><surname>Cypel</surname><given-names>M.C.</given-names></name>
<name><surname>Ferraz</surname><given-names>N.N.</given-names></name>
<name><surname>Furtado</surname><given-names>J.M.</given-names></name>
<name><surname>Sacai</surname><given-names>P.Y.</given-names></name>
<name><surname>Mu&#x000f1;oz</surname><given-names>S.</given-names></name>
<name><surname>Cunha</surname><given-names>C.C.</given-names></name>
<etal/>
</person-group><article-title>Prevalence of ocular findings regardless of visual acuity status in older adults from the Brazilian Amazon Region</article-title><source>Sci. Rep.</source><year>2021</year><volume>11</volume><elocation-id>23710</elocation-id><pub-id pub-id-type="doi">10.1038/s41598-021-03172-4</pub-id><pub-id pub-id-type="pmid">34887482</pub-id>
</element-citation></ref><ref id="B18-vision-09-00042"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Page</surname><given-names>M.J.</given-names></name>
<name><surname>McKenzie</surname><given-names>J.E.</given-names></name>
<name><surname>Bossuyt</surname><given-names>P.M.</given-names></name>
<name><surname>Boutron</surname><given-names>I.</given-names></name>
<name><surname>Hoffmann</surname><given-names>T.C.</given-names></name>
<name><surname>Mulrow</surname><given-names>C.D.</given-names></name>
<name><surname>Shamseer</surname><given-names>L.</given-names></name>
<name><surname>Tetzlaff</surname><given-names>J.M.</given-names></name>
<name><surname>Akl</surname><given-names>E.A.</given-names></name>
<name><surname>Brennan</surname><given-names>S.E.</given-names></name>
<etal/>
</person-group><article-title>The PRISMA 2020 statement: An updated guideline for reporting systematic reviews</article-title><source>BMJ</source><year>2021</year><volume>372</volume><fpage>71</fpage><pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id></element-citation></ref><ref id="B19-vision-09-00042"><label>19.</label><element-citation publication-type="book"><person-group person-group-type="editor">
<name><surname>Higgins</surname><given-names>J.P.T.</given-names></name>
<name><surname>Thomas</surname><given-names>J.</given-names></name>
<name><surname>Chandler</surname><given-names>J.</given-names></name>
<name><surname>Cumpston</surname><given-names>M.</given-names></name>
<name><surname>Li</surname><given-names>T.</given-names></name>
<name><surname>Page</surname><given-names>M.J.</given-names></name>
<name><surname>Welch</surname><given-names>V.A.</given-names></name>
</person-group><source>Cochrane Handbook for Systematic Reviews of Interventions, Version 6.4 (Updated August 2023)</source><publisher-name>Cochrane</publisher-name><publisher-loc>London, UK</publisher-loc><year>2023</year><comment>Available online: <ext-link xlink:href="www.training.cochrane.org/handbook" ext-link-type="uri">www.training.cochrane.org/handbook</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2024-02-15">(accessed on 15 February 2024)</date-in-citation></element-citation></ref><ref id="B20-vision-09-00042"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>P&#x000f3;voa</surname><given-names>C.A.</given-names></name>
<name><surname>Nicolela</surname><given-names>M.T.</given-names></name>
<name><surname>Valle</surname><given-names>A.L.S.L.</given-names></name>
<name><surname>Gomes</surname><given-names>L.E.d.S.</given-names></name>
<name><surname>Neustein</surname><given-names>I.</given-names></name>
</person-group><article-title>Preval&#x000ea;ncia de glaucoma identificada em campanha de detec&#x000e7;&#x000e3;o em S&#x000e3;o Paulo</article-title><source>Arq. Bras. Oftalmol.</source><year>2001</year><volume>64</volume><fpage>303</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.1590/S0004-27492001000400006</pub-id></element-citation></ref><ref id="B21-vision-09-00042"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mitchell</surname><given-names>J.P.</given-names></name>
<name><surname>Williams</surname><given-names>N.</given-names></name>
<name><surname>Martin</surname><given-names>R.</given-names></name>
<name><surname>Keshava</surname><given-names>P.</given-names></name>
<name><surname>Bynum</surname><given-names>M.M.</given-names></name>
<name><surname>Figueroa</surname><given-names>M.</given-names></name>
<name><surname>Yancy</surname><given-names>A.</given-names></name>
<name><surname>DellaRocca</surname><given-names>R.</given-names></name>
</person-group><article-title>The Venezuela eye evaluation study</article-title><source>J. Natl. Med. Assoc.</source><year>2008</year><volume>100</volume><fpage>435</fpage><lpage>438</lpage><pub-id pub-id-type="doi">10.1016/S0027-9684(15)31278-5</pub-id><pub-id pub-id-type="pmid">18481484</pub-id>
</element-citation></ref><ref id="B22-vision-09-00042"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alvarado</surname><given-names>D.</given-names></name>
<name><surname>Rivera</surname><given-names>B.</given-names></name>
<name><surname>Lagos</surname><given-names>L.</given-names></name>
<name><surname>Ochoa</surname><given-names>M.</given-names></name>
<name><surname>Starkman</surname><given-names>I.</given-names></name>
<name><surname>Castillo</surname><given-names>M.</given-names></name>
<name><surname>Flores</surname><given-names>E.</given-names></name>
<name><surname>Lansingh</surname><given-names>V.C.</given-names></name>
<name><surname>Limburg</surname><given-names>H.</given-names></name>
<name><surname>Silva</surname><given-names>J.C.</given-names></name>
</person-group><article-title>Encuesta nacional de ceguera y deficiencia visual evitables en Honduras</article-title><source>Rev. Panam. Salud P&#x000fa;blica</source><year>2014</year><volume>36</volume><fpage>300</fpage><lpage>305</lpage><pub-id pub-id-type="pmid">25604099</pub-id>
</element-citation></ref><ref id="B23-vision-09-00042"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Campos</surname><given-names>B.</given-names></name>
<name><surname>Cerrate</surname><given-names>A.</given-names></name>
<name><surname>Montjoy</surname><given-names>E.</given-names></name>
<name><surname>Dulanto Gomero</surname><given-names>V.</given-names></name>
<name><surname>Gonzales</surname><given-names>C.</given-names></name>
<name><surname>Tecse</surname><given-names>A.</given-names></name>
<name><surname>Pariamachi</surname><given-names>A.</given-names></name>
<name><surname>Lansingh</surname><given-names>V.C.</given-names></name>
<name><surname>Dulanto Reinoso</surname><given-names>V.</given-names></name>
<name><surname>Minaya Barba</surname><given-names>J.</given-names></name>
<etal/>
</person-group><article-title>Prevalencia y causas de ceguera en Per&#x000fa;: Encuesta nacional</article-title><source>Rev. Panam. Salud Publica-Pan Am. J. Public Health</source><year>2014</year><volume>36</volume><fpage>283</fpage><lpage>289</lpage></element-citation></ref><ref id="B24-vision-09-00042"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gallarreta</surname><given-names>M.</given-names></name>
<name><surname>Furtado</surname><given-names>J.M.</given-names></name>
<name><surname>Lansingh</surname><given-names>V.C.</given-names></name>
<name><surname>Silva</surname><given-names>J.C.</given-names></name>
<name><surname>Limburg</surname><given-names>H.</given-names></name>
</person-group><article-title>Rapid assessment of avoidable blindness in Uruguay: Results of a nationwide survey</article-title><source>Rev. Panam Salud Publica</source><year>2014</year><volume>36</volume><fpage>219</fpage><lpage>224</lpage><pub-id pub-id-type="pmid">25563146</pub-id>
</element-citation></ref><ref id="B25-vision-09-00042"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lopez-Ramos</surname><given-names>A.</given-names></name>
<name><surname>Gomez-Bastar</surname><given-names>P.A.</given-names></name>
<name><surname>Lansingh</surname><given-names>V.C.</given-names></name>
<name><surname>Rodriguez-Gomez</surname><given-names>J.A.</given-names></name>
<name><surname>Vargas-Fragoso</surname><given-names>V.</given-names></name>
<name><surname>Soria-Arellano</surname><given-names>F.A.</given-names></name>
<name><surname>Silva-Camacho</surname><given-names>S.H.</given-names></name>
<name><surname>Castillo-Velazquez</surname><given-names>J.</given-names></name>
<name><surname>Zepeda-Romero</surname><given-names>L.C.</given-names></name>
<name><surname>Limburg</surname><given-names>H.</given-names></name>
</person-group><article-title>Rapid assessment of avoidable blindness: Prevalence of blindness, visual impairment and diabetes in nuevo leon, Mexico 2014</article-title><source>Ophthalmic Epidemiol.</source><year>2018</year><volume>25</volume><fpage>412</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1080/09286586.2018.1501498</pub-id><pub-id pub-id-type="pmid">30081687</pub-id>
</element-citation></ref><ref id="B26-vision-09-00042"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Duerksen</surname><given-names>R.</given-names></name>
<name><surname>Limburg</surname><given-names>H.</given-names></name>
<name><surname>Lansingh</surname><given-names>V.C.</given-names></name>
<name><surname>Silva</surname><given-names>J.C.</given-names></name>
</person-group><article-title>Review of blindness and visual impairment in paraguay: Changes between 1999 and 2011</article-title><source>Ophthalmic Epidemiol.</source><year>2013</year><volume>20</volume><fpage>301</fpage><lpage>307</lpage><pub-id pub-id-type="doi">10.3109/09286586.2013.821497</pub-id><pub-id pub-id-type="pmid">24070101</pub-id>
</element-citation></ref><ref id="B27-vision-09-00042"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barrenechea</surname><given-names>R.</given-names></name>
<name><surname>la Fuente</surname><given-names>I.D.</given-names></name>
<name><surname>Plaza</surname><given-names>R.G.</given-names></name>
<name><surname>Flores</surname><given-names>N.</given-names></name>
<name><surname>Segovia</surname><given-names>L.</given-names></name>
<name><surname>Villag&#x000f3;mez</surname><given-names>Z.</given-names></name>
<name><surname>Camarero</surname><given-names>E.E.</given-names></name>
<name><surname>Zepeda-Romero</surname><given-names>L.C.</given-names></name>
<name><surname>Lansingh</surname><given-names>V.C.</given-names></name>
<name><surname>Limburg</surname><given-names>H.</given-names></name>
<etal/>
</person-group><article-title>Encuesta nacional de ceguera y deficiencia visual evitable en Argentina, 2013</article-title><source>Rev. Panam. Salud P&#x000fa;blica</source><year>2015</year><volume>37</volume><fpage>7</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">25791183</pub-id>
</element-citation></ref><ref id="B28-vision-09-00042"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Castell&#x000f3;n</surname><given-names>R.I.A.</given-names></name>
<name><surname>Vargas</surname><given-names>E.C.</given-names></name>
<name><surname>Chavarr&#x000ed;a</surname><given-names>R.E.C.</given-names></name>
<name><surname>Vargas</surname><given-names>G.A.R.</given-names></name>
</person-group><article-title>Rapid assessment of avoidable blindness and diabetic retinopathy in individuals aged 50 years or older in Costa Rica</article-title><source>PLoS ONE</source><year>2019</year><volume>14</volume><elocation-id>e0212660</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0212660</pub-id><pub-id pub-id-type="pmid">30789973</pub-id>
</element-citation></ref><ref id="B29-vision-09-00042"><label>29.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Harrer</surname><given-names>M.</given-names></name>
<name><surname>Cuijpers</surname><given-names>P.</given-names></name>
<name><surname>Furukawa</surname><given-names>T.</given-names></name>
<name><surname>Ebert</surname><given-names>D.</given-names></name>
</person-group><source>Doing Meta-Analysis with R: A Hands-On Guide</source><publisher-name>Chapman and Hall/CRC</publisher-name><publisher-loc>Boca Raton, FL, USA</publisher-loc><year>2021</year></element-citation></ref><ref id="B30-vision-09-00042"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Takkouche</surname><given-names>B.</given-names></name>
<name><surname>Cadarso-Su&#x000e1;rez</surname><given-names>C.</given-names></name>
<name><surname>Spiegelman</surname><given-names>D.</given-names></name>
</person-group><article-title>Evaluation of old and new tests of heterogeneity in epidemiologic meta-analysis</article-title><source>Am. J. Epidemiol.</source><year>1999</year><volume>150</volume><fpage>206</fpage><lpage>215</lpage><pub-id pub-id-type="doi">10.1093/oxfordjournals.aje.a009981</pub-id><pub-id pub-id-type="pmid">10412966</pub-id>
</element-citation></ref><ref id="B31-vision-09-00042"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Duval</surname><given-names>S.</given-names></name>
<name><surname>Tweedie</surname><given-names>R.</given-names></name>
</person-group><article-title>Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis</article-title><source>Biometrics</source><year>2000</year><volume>56</volume><fpage>455</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1111/j.0006-341X.2000.00455.x</pub-id><pub-id pub-id-type="pmid">10877304</pub-id>
</element-citation></ref><ref id="B32-vision-09-00042"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Begg</surname><given-names>C.B.</given-names></name>
<name><surname>Mazumdar</surname><given-names>M.</given-names></name>
</person-group><article-title>Operating characteristics of a rank correlation test for publication bias</article-title><source>Biometrics</source><year>1994</year><volume>50</volume><fpage>1088</fpage><lpage>1101</lpage><pub-id pub-id-type="doi">10.2307/2533446</pub-id><pub-id pub-id-type="pmid">7786990</pub-id>
</element-citation></ref><ref id="B33-vision-09-00042"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Viechtbauer</surname><given-names>W.</given-names></name>
</person-group><article-title>Conducting Meta-Analyses in <italic toggle="yes">R</italic> with The meta for Package</article-title><source>J. Stat. Softw.</source><year>2010</year><volume>36</volume><fpage>1</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.18637/jss.v036.i03</pub-id></element-citation></ref><ref id="B34-vision-09-00042"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Downs</surname><given-names>S.H.</given-names></name>
<name><surname>Black</surname><given-names>N.</given-names></name>
</person-group><article-title>The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions</article-title><source>J. Epidemiol. Community Health</source><year>1998</year><volume>52</volume><fpage>377</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1136/jech.52.6.377</pub-id><pub-id pub-id-type="pmid">9764259</pub-id>
</element-citation></ref><ref id="B35-vision-09-00042"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Reis</surname><given-names>T.F.</given-names></name>
<name><surname>Paula</surname><given-names>J.S.</given-names></name>
<name><surname>Furtado</surname><given-names>J.M.</given-names></name>
</person-group><article-title>Primary glaucomas in adults: Epidemiology and public health-A review</article-title><source>Clin. Exp. Ophthalmol.</source><year>2022</year><volume>50</volume><fpage>128</fpage><lpage>142</lpage><pub-id pub-id-type="doi">10.1111/ceo.14040</pub-id><pub-id pub-id-type="pmid">35037725</pub-id>
</element-citation></ref><ref id="B36-vision-09-00042"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rudnicka</surname><given-names>A.R.</given-names></name>
<name><surname>Mt-Isa</surname><given-names>S.</given-names></name>
<name><surname>Owen</surname><given-names>C.G.</given-names></name>
<name><surname>Cook</surname><given-names>D.G.</given-names></name>
<name><surname>Ashby</surname><given-names>D.</given-names></name>
</person-group><article-title>Variations in primary open-angle glaucoma prevalence by age, gender, and race: A bayesian meta-analysis</article-title><source>Investig. Opthalmology Vis. Sci.</source><year>2006</year><volume>47</volume><fpage>4254</fpage><lpage>4261</lpage><pub-id pub-id-type="doi">10.1167/iovs.06-0299</pub-id></element-citation></ref><ref id="B37-vision-09-00042"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vajaranant</surname><given-names>T.S.</given-names></name>
<name><surname>Nayak</surname><given-names>S.</given-names></name>
<name><surname>Wilensky</surname><given-names>J.T.</given-names></name>
<name><surname>E Joslin</surname><given-names>C.</given-names></name>
</person-group><article-title>Gender and glaucoma: What we know and what we need to know</article-title><source>Curr. Opin. Ophthalmol.</source><year>2010</year><volume>21</volume><fpage>91</fpage><lpage>99</lpage><pub-id pub-id-type="doi">10.1097/ICU.0b013e3283360b7e</pub-id><pub-id pub-id-type="pmid">20051857</pub-id>
</element-citation></ref><ref id="B38-vision-09-00042"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Higginbotham</surname><given-names>E.J.</given-names></name>
</person-group><article-title>Does sex matter in glaucoma?</article-title><source>Arch. Ophthalmol.</source><year>2004</year><volume>122</volume><fpage>374</fpage><lpage>375</lpage><pub-id pub-id-type="doi">10.1001/archopht.122.3.374</pub-id><pub-id pub-id-type="pmid">15006853</pub-id>
</element-citation></ref><ref id="B39-vision-09-00042"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hulsman</surname><given-names>C.A.A.</given-names></name>
<name><surname>Westendorp</surname><given-names>I.C.D.</given-names></name>
<name><surname>Ramrattan</surname><given-names>R.S.</given-names></name>
<name><surname>Wolfs</surname><given-names>R.C.W.</given-names></name>
<name><surname>Witteman</surname><given-names>J.C.M.</given-names></name>
<name><surname>Vingerling</surname><given-names>J.R.</given-names></name>
<name><surname>Hofman</surname><given-names>A.</given-names></name>
<name><surname>de Jong</surname><given-names>P.T.V.M.</given-names></name>
</person-group><article-title>Is open-angle glaucoma associated with early menopause?: The Rotterdam Study</article-title><source>Am. J. Epidemiol.</source><year>2001</year><volume>154</volume><fpage>138</fpage><lpage>144</lpage><pub-id pub-id-type="doi">10.1093/aje/154.2.138</pub-id><pub-id pub-id-type="pmid">11447046</pub-id>
</element-citation></ref><ref id="B40-vision-09-00042"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mark</surname><given-names>H.H.</given-names></name>
</person-group><article-title>Gender differences in glaucoma and ocular hypertension</article-title><source>Arch. Ophthalmol.</source><year>2005</year><volume>123</volume><fpage>284</fpage><pub-id pub-id-type="doi">10.1001/archopht.123.2.284-a</pub-id></element-citation></ref><ref id="B41-vision-09-00042"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Amerasinghe</surname><given-names>N.</given-names></name>
<name><surname>Aung</surname><given-names>T.</given-names></name>
</person-group><article-title>Angle-closure: Risk factors, diagnosis and treatment</article-title><source>Prog. Brain Res.</source><year>2008</year><volume>173</volume><fpage>31</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1016/S0079-6123(08)01104-7</pub-id><pub-id pub-id-type="pmid">18929100</pub-id>
</element-citation></ref><ref id="B42-vision-09-00042"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Drance</surname><given-names>S.</given-names></name>
<name><surname>Anderson</surname><given-names>D.R.</given-names></name>
<name><surname>Schulzer</surname><given-names>M.</given-names></name>
<collab>Group CN-TGS</collab>
</person-group><article-title>Risk factors for progression of visual field abnormalities in normal-tension glaucoma</article-title><source>Am. J. Ophthalmol.</source><year>2001</year><volume>131</volume><fpage>699</fpage><lpage>708</lpage><pub-id pub-id-type="doi">10.1016/S0002-9394(01)00964-3</pub-id><pub-id pub-id-type="pmid">11384564</pub-id>
</element-citation></ref><ref id="B43-vision-09-00042"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Quigley</surname><given-names>H.A.</given-names></name>
<name><surname>Broman</surname><given-names>A.T.</given-names></name>
</person-group><article-title>The number of people with glaucoma worldwide in 2010 and 2020</article-title><source>Br. J. Ophthalmol.</source><year>2006</year><volume>90</volume><fpage>262</fpage><lpage>267</lpage><pub-id pub-id-type="doi">10.1136/bjo.2005.081224</pub-id><pub-id pub-id-type="pmid">16488940</pub-id>
</element-citation></ref><ref id="B44-vision-09-00042"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Foster</surname><given-names>P.J.</given-names></name>
<name><surname>Broadway</surname><given-names>D.C.</given-names></name>
<name><surname>Hayat</surname><given-names>S.</given-names></name>
<name><surname>Luben</surname><given-names>R.</given-names></name>
<name><surname>Dalzell</surname><given-names>N.</given-names></name>
<name><surname>Bingham</surname><given-names>S.</given-names></name>
<name><surname>Wareham</surname><given-names>N.J.</given-names></name>
<name><surname>Khaw</surname><given-names>K.-T.</given-names></name>
</person-group><article-title>Refractive error, axial length and anterior chamber depth of the eye in British adults: The EPIC-Norfolk Eye Study</article-title><source>Br. J. Ophthalmol.</source><year>2010</year><volume>94</volume><fpage>827</fpage><lpage>830</lpage><pub-id pub-id-type="doi">10.1136/bjo.2009.163899</pub-id><pub-id pub-id-type="pmid">20606021</pub-id>
</element-citation></ref><ref id="B45-vision-09-00042"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hashemi</surname><given-names>H.</given-names></name>
<name><surname>Khabazkhoob</surname><given-names>M.</given-names></name>
<name><surname>Miraftab</surname><given-names>M.</given-names></name>
<name><surname>Emamian</surname><given-names>M.H.</given-names></name>
<name><surname>Shariati</surname><given-names>M.</given-names></name>
<name><surname>Abdolahinia</surname><given-names>T.</given-names></name>
<name><surname>Fotouhi</surname><given-names>A.</given-names></name>
</person-group><article-title>The distribution of axial length, anterior chamber depth, lens thickness, and vitreous chamber depth in an adult population of Shahroud, Iran</article-title><source>BMC Ophthalmol.</source><year>2012</year><volume>12</volume><elocation-id>50</elocation-id><pub-id pub-id-type="doi">10.1186/1471-2415-12-50</pub-id><pub-id pub-id-type="pmid">22988958</pub-id>
</element-citation></ref><ref id="B46-vision-09-00042"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chen</surname><given-names>H.</given-names></name>
<name><surname>Lin</surname><given-names>H.</given-names></name>
<name><surname>Lin</surname><given-names>Z.</given-names></name>
<name><surname>Chen</surname><given-names>J.</given-names></name>
<name><surname>Chen</surname><given-names>W.</given-names></name>
</person-group><article-title>Distribution of axial length, anterior chamber depth, and corneal curvature in an aged population in South China</article-title><source>BMC Ophthalmol.</source><year>2016</year><volume>16</volume><elocation-id>47</elocation-id><pub-id pub-id-type="doi">10.1186/s12886-016-0221-5</pub-id><pub-id pub-id-type="pmid">27138378</pub-id>
</element-citation></ref><ref id="B47-vision-09-00042"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cedrone</surname><given-names>C.</given-names></name>
<name><surname>Mancino</surname><given-names>R.</given-names></name>
<name><surname>Cerulli</surname><given-names>A.</given-names></name>
<name><surname>Cesareo</surname><given-names>M.</given-names></name>
<name><surname>Nucci</surname><given-names>C.</given-names></name>
</person-group><article-title>Epidemiology of primary glaucoma: Prevalence, incidence, and blinding effects</article-title><source>Prog. Brain Res.</source><year>2008</year><volume>173</volume><fpage>3</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1016/S0079-6123(08)01101-1</pub-id><pub-id pub-id-type="pmid">18929097</pub-id>
</element-citation></ref><ref id="B48-vision-09-00042"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sun</surname><given-names>Y.</given-names></name>
<name><surname>Chen</surname><given-names>A.</given-names></name>
<name><surname>Zou</surname><given-names>M.</given-names></name>
<name><surname>Zhang</surname><given-names>Y.</given-names></name>
<name><surname>Jin</surname><given-names>L.</given-names></name>
<name><surname>Li</surname><given-names>Y.</given-names></name>
<name><surname>Zheng</surname><given-names>D.</given-names></name>
<name><surname>Jin</surname><given-names>G.</given-names></name>
<name><surname>Congdon</surname><given-names>N.</given-names></name>
</person-group><article-title>Time trends, associations and prevalence of blindness and vision loss due to glaucoma: An analysis of observational data from the Global Burden of Disease Study 2017</article-title><source>BMJ Open</source><year>2022</year><volume>12</volume><fpage>e053805</fpage><pub-id pub-id-type="doi">10.1136/bmjopen-2021-053805</pub-id><pub-id pub-id-type="pmid">34992115</pub-id>
</element-citation></ref><ref id="B49-vision-09-00042"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Davuluru</surname><given-names>S.S.</given-names></name>
<name><surname>Jess</surname><given-names>A.T.</given-names></name>
<name><surname>Bin Kim</surname><given-names>J.S.</given-names></name>
<name><surname>Yoo</surname><given-names>K.</given-names></name>
<name><surname>Nguyen</surname><given-names>V.</given-names></name>
<name><surname>Xu</surname><given-names>B.Y.</given-names></name>
</person-group><article-title>Identifying, Understanding, and Addressing Disparities in Glaucoma Care in the United States</article-title><source>Transl. Vis. Sci. Technol.</source><year>2023</year><volume>12</volume><fpage>18</fpage><pub-id pub-id-type="doi">10.1167/tvst.12.10.18</pub-id></element-citation></ref><ref id="B50-vision-09-00042"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garg</surname><given-names>H.</given-names></name>
<name><surname>Singh</surname><given-names>L.K.</given-names></name>
<name><surname>Khanna</surname><given-names>M.</given-names></name>
<name><surname>Pooja</surname><given-names>N.</given-names></name>
</person-group><article-title>Performance analysis of machine learning techniques for glaucoma detection based on textural and intensity features</article-title><source>Int. J. Innov. Comput. Appl.</source><year>2020</year><volume>11</volume><fpage>216</fpage><pub-id pub-id-type="doi">10.1504/IJICA.2020.111230</pub-id></element-citation></ref><ref id="B51-vision-09-00042"><label>51.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Singh</surname><given-names>L.K.</given-names></name>
<name><surname>Pooja</surname></name>
<name><surname>Garg</surname><given-names>H.</given-names></name>
<name><surname>Khanna</surname><given-names>M.</given-names></name>
</person-group><article-title>Histogram of Oriented Gradients (HOG)-Based Artificial Neural Network (ANN) Classifier for Glaucoma Detection</article-title><source>Int. J. Swarm Intell. Res.</source><year>2022</year><volume>13</volume><fpage>1</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.4018/IJSIR.309940</pub-id></element-citation></ref><ref id="B52-vision-09-00042"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Singh</surname><given-names>L.K.</given-names></name>
<name><surname>Khanna</surname><given-names>M.</given-names></name>
<name><surname>Thawkar</surname><given-names>S.</given-names></name>
<name><surname>Singh</surname><given-names>R.</given-names></name>
</person-group><article-title>A novel hybridized feature selection strategy for the effective prediction of glaucoma in retinal fundus images</article-title><source>Multimed. Tools Appl.</source><year>2023</year><volume>83</volume><fpage>46087</fpage><lpage>46159</lpage><pub-id pub-id-type="doi">10.1007/s11042-023-17081-3</pub-id></element-citation></ref><ref id="B53-vision-09-00042"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Assefa</surname><given-names>A.</given-names></name>
<name><surname>Bihon</surname><given-names>A.</given-names></name>
</person-group><article-title>A systematic review and meta-analysis of prevalence of Escherichia coli in foods of animal origin in Ethiopia</article-title><source>Heliyon</source><year>2018</year><volume>4</volume><fpage>e00716</fpage><pub-id pub-id-type="doi">10.1016/j.heliyon.2018.e00716</pub-id><pub-id pub-id-type="pmid">30105310</pub-id>
</element-citation></ref><ref id="B54-vision-09-00042"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guedes</surname><given-names>J.</given-names></name>
<name><surname>Neto</surname><given-names>A.B.d.C.</given-names></name>
<name><surname>Fernandes</surname><given-names>B.F.</given-names></name>
<name><surname>Faneli</surname><given-names>A.C.</given-names></name>
<name><surname>Ferreira</surname><given-names>M.A.</given-names></name>
<name><surname>Amaral</surname><given-names>D.C.</given-names></name>
<name><surname>Mora-Paez</surname><given-names>D.J.</given-names></name>
<name><surname>Ambr&#x000f3;sio</surname><given-names>R.</given-names></name>
</person-group><article-title>Myopia Prevalence in Latin American Children and Adolescents: A Systematic Review and Meta-Analysis</article-title><source>Cureus</source><year>2024</year><volume>16</volume><fpage>e63482</fpage><pub-id pub-id-type="doi">10.7759/cureus.63482</pub-id><pub-id pub-id-type="pmid">38952594</pub-id>
</element-citation></ref><ref id="B55-vision-09-00042"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Costa Neto</surname><given-names>A.</given-names></name>
<name><surname>Guedes</surname><given-names>J.</given-names></name>
<name><surname>Mora-Paez</surname><given-names>D.J.</given-names></name>
<name><surname>Ferreira</surname><given-names>M.A.</given-names></name>
<name><surname>Faneli</surname><given-names>A.C.</given-names></name>
<name><surname>Amaral</surname><given-names>D.C.</given-names></name>
<name><surname>Pereira</surname><given-names>S.</given-names></name>
<name><surname>Almeida</surname><given-names>G.</given-names></name>
<name><surname>Manteufel</surname><given-names>V.</given-names></name>
<name><surname>Haddad Neto</surname><given-names>J.S.</given-names></name>
<etal/>
</person-group><article-title>Systematic review and meta-analysis of myopia prevalence in Brazilian school children</article-title><source>Rev. Bras. Oftalmol.</source><year>2024</year><volume>83</volume><fpage>e0056</fpage><pub-id pub-id-type="doi">10.37039/1982.8551.20240056</pub-id></element-citation></ref><ref id="B56-vision-09-00042"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nikolakopoulou</surname><given-names>A.</given-names></name>
<name><surname>Mavridis</surname><given-names>D.</given-names></name>
<name><surname>Salanti</surname><given-names>G.</given-names></name>
</person-group><article-title>Demystifying fixed and random effects meta-analysis</article-title><source>Evid. Based Ment. Health</source><year>2014</year><volume>17</volume><fpage>53</fpage><lpage>57</lpage><pub-id pub-id-type="doi">10.1136/eb-2014-101795</pub-id><pub-id pub-id-type="pmid">24692250</pub-id>
</element-citation></ref><ref id="B57-vision-09-00042"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ades</surname><given-names>A.E.</given-names></name>
<name><surname>Lu</surname><given-names>G.</given-names></name>
<name><surname>Higgins</surname><given-names>J.P.T.</given-names></name>
</person-group><article-title>The interpretation of random-effects meta-analysis in decision models</article-title><source>Med. Decis. Mak.</source><year>2005</year><volume>25</volume><fpage>646</fpage><lpage>654</lpage><pub-id pub-id-type="doi">10.1177/0272989X05282643</pub-id></element-citation></ref><ref id="B58-vision-09-00042"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cheng</surname><given-names>J.-W.</given-names></name>
<name><surname>Zong</surname><given-names>Y.</given-names></name>
<name><surname>Zeng</surname><given-names>Y.-Y.</given-names></name>
<name><surname>Wei</surname><given-names>R.-L.</given-names></name>
</person-group><article-title>The prevalence of primary angle closure glaucoma in adult asians: A systematic review and meta-analysis</article-title><source>PLoS ONE</source><year>2014</year><volume>9</volume><elocation-id>e103222</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0103222</pub-id><pub-id pub-id-type="pmid">25057993</pub-id>
</element-citation></ref></ref-list></back><floats-group><fig position="float" id="vision-09-00042-f001"><label>Figure 1</label><caption><p>PRISMA flow diagram of the study screening and selection process.</p></caption><graphic xlink:href="vision-09-00042-g001" position="float"/></fig><fig position="float" id="vision-09-00042-f002"><label>Figure 2</label><caption><p>Forest plot of eligible studies on the overall Latin American prevalence of glaucoma in the general population [<xref rid="B15-vision-09-00042" ref-type="bibr">15</xref>,<xref rid="B16-vision-09-00042" ref-type="bibr">16</xref>,<xref rid="B17-vision-09-00042" ref-type="bibr">17</xref>,<xref rid="B20-vision-09-00042" ref-type="bibr">20</xref>,<xref rid="B21-vision-09-00042" ref-type="bibr">21</xref>].</p></caption><graphic xlink:href="vision-09-00042-g002" position="float"/></fig><fig position="float" id="vision-09-00042-f003"><label>Figure 3</label><caption><p>Forest plot of eligible studies on the overall Latin American prevalence of glaucoma in patients with visual acuity &#x0003c; 20/60 [<xref rid="B22-vision-09-00042" ref-type="bibr">22</xref>,<xref rid="B23-vision-09-00042" ref-type="bibr">23</xref>,<xref rid="B24-vision-09-00042" ref-type="bibr">24</xref>,<xref rid="B25-vision-09-00042" ref-type="bibr">25</xref>,<xref rid="B26-vision-09-00042" ref-type="bibr">26</xref>,<xref rid="B27-vision-09-00042" ref-type="bibr">27</xref>,<xref rid="B28-vision-09-00042" ref-type="bibr">28</xref>].</p></caption><graphic xlink:href="vision-09-00042-g003" position="float"/></fig><fig position="float" id="vision-09-00042-f004"><label>Figure 4</label><caption><p>Forest plot of eligible studies on the differences in the prevalence of glaucoma in Latin America based on sex [<xref rid="B15-vision-09-00042" ref-type="bibr">15</xref>,<xref rid="B16-vision-09-00042" ref-type="bibr">16</xref>,<xref rid="B20-vision-09-00042" ref-type="bibr">20</xref>,<xref rid="B21-vision-09-00042" ref-type="bibr">21</xref>].</p></caption><graphic xlink:href="vision-09-00042-g004" position="float"/></fig><fig position="float" id="vision-09-00042-f005"><label>Figure 5</label><caption><p>Forest plot of eligible studies on the Latin American prevalence of glaucoma in individuals with moderate vision impairment [<xref rid="B22-vision-09-00042" ref-type="bibr">22</xref>,<xref rid="B23-vision-09-00042" ref-type="bibr">23</xref>,<xref rid="B24-vision-09-00042" ref-type="bibr">24</xref>,<xref rid="B25-vision-09-00042" ref-type="bibr">25</xref>,<xref rid="B26-vision-09-00042" ref-type="bibr">26</xref>,<xref rid="B27-vision-09-00042" ref-type="bibr">27</xref>,<xref rid="B28-vision-09-00042" ref-type="bibr">28</xref>].</p></caption><graphic xlink:href="vision-09-00042-g005" position="float"/></fig><fig position="float" id="vision-09-00042-f006"><label>Figure 6</label><caption><p>Forest plot of eligible studies on the Latin American prevalence of glaucoma in individuals with severe vision impairment [<xref rid="B22-vision-09-00042" ref-type="bibr">22</xref>,<xref rid="B23-vision-09-00042" ref-type="bibr">23</xref>,<xref rid="B24-vision-09-00042" ref-type="bibr">24</xref>,<xref rid="B25-vision-09-00042" ref-type="bibr">25</xref>,<xref rid="B26-vision-09-00042" ref-type="bibr">26</xref>,<xref rid="B27-vision-09-00042" ref-type="bibr">27</xref>,<xref rid="B28-vision-09-00042" ref-type="bibr">28</xref>].</p></caption><graphic xlink:href="vision-09-00042-g006" position="float"/></fig><fig position="float" id="vision-09-00042-f007"><label>Figure 7</label><caption><p>Forest plot of eligible studies on the Latin American prevalence of glaucoma in blind individuals [<xref rid="B22-vision-09-00042" ref-type="bibr">22</xref>,<xref rid="B23-vision-09-00042" ref-type="bibr">23</xref>,<xref rid="B24-vision-09-00042" ref-type="bibr">24</xref>,<xref rid="B25-vision-09-00042" ref-type="bibr">25</xref>,<xref rid="B26-vision-09-00042" ref-type="bibr">26</xref>,<xref rid="B27-vision-09-00042" ref-type="bibr">27</xref>,<xref rid="B28-vision-09-00042" ref-type="bibr">28</xref>].</p></caption><graphic xlink:href="vision-09-00042-g007" position="float"/></fig><fig position="float" id="vision-09-00042-f008"><label>Figure 8</label><caption><p>Funnel plot analysis for quality and evidence assessment and risk of bias in 13 studies on the prevalence of glaucoma in Latin America.</p></caption><graphic xlink:href="vision-09-00042-g008" position="float"/></fig><table-wrap position="float" id="vision-09-00042-t001"><object-id pub-id-type="pii">vision-09-00042-t001_Table 1</object-id><label>Table 1</label><caption><p>Baseline Characteristics of included studies.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Author</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Year</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Location</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Age Inclusion</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Mean Age</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">N Total</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">N Total (M/F)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">N Glaucoma</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">N Glaucoma (M/F)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Quality Score</th></tr></thead><tbody><tr><td colspan="10" align="center" valign="middle" rowspan="1">Group 1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Sakata</td><td align="center" valign="middle" rowspan="1" colspan="1">2003</td><td align="center" valign="middle" rowspan="1" colspan="1">Brazil</td><td align="center" valign="middle" rowspan="1" colspan="1">40 at least</td><td align="center" valign="middle" rowspan="1" colspan="1">53.7</td><td align="center" valign="middle" rowspan="1" colspan="1">1636</td><td align="center" valign="middle" rowspan="1" colspan="1">696/940</td><td align="center" valign="middle" rowspan="1" colspan="1">56</td><td align="center" valign="middle" rowspan="1" colspan="1">24/32</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Povoa</td><td align="center" valign="middle" rowspan="1" colspan="1">1997</td><td align="center" valign="middle" rowspan="1" colspan="1">Brazil</td><td align="center" valign="middle" rowspan="1" colspan="1">40 at least</td><td align="center" valign="middle" rowspan="1" colspan="1">58.2</td><td align="center" valign="middle" rowspan="1" colspan="1">1438</td><td align="center" valign="middle" rowspan="1" colspan="1">396/937</td><td align="center" valign="middle" rowspan="1" colspan="1">105</td><td align="center" valign="middle" rowspan="1" colspan="1">46/59</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mitchell</td><td align="center" valign="middle" rowspan="1" colspan="1">2008</td><td align="center" valign="middle" rowspan="1" colspan="1">Venezuela</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">1261</td><td align="center" valign="middle" rowspan="1" colspan="1">481/780</td><td align="center" valign="middle" rowspan="1" colspan="1">12</td><td align="center" valign="middle" rowspan="1" colspan="1">5/7</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Castellanos-Perilla</td><td align="center" valign="middle" rowspan="1" colspan="1">2015</td><td align="center" valign="middle" rowspan="1" colspan="1">Colombia</td><td align="center" valign="middle" rowspan="1" colspan="1">60 at least</td><td align="center" valign="middle" rowspan="1" colspan="1">69.11</td><td align="center" valign="middle" rowspan="1" colspan="1">18,912</td><td align="center" valign="middle" rowspan="1" colspan="1">8308/10,604</td><td align="center" valign="middle" rowspan="1" colspan="1">1072</td><td align="center" valign="middle" rowspan="1" colspan="1">407/665</td><td align="center" valign="middle" rowspan="1" colspan="1">10</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fernandes</td><td align="center" valign="middle" rowspan="1" colspan="1">2021</td><td align="center" valign="middle" rowspan="1" colspan="1">Brazil</td><td align="center" valign="middle" rowspan="1" colspan="1">45 at least</td><td align="center" valign="middle" rowspan="1" colspan="1">60.33</td><td align="center" valign="middle" rowspan="1" colspan="1">2041</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">180</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td></tr><tr><td colspan="10" align="center" valign="middle" rowspan="1">Group 2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Gallarreta</td><td align="center" valign="middle" rowspan="1" colspan="1">2011</td><td align="center" valign="middle" rowspan="1" colspan="1">Uruguay</td><td align="center" valign="middle" rowspan="1" colspan="1">50 at least</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">3729</td><td align="center" valign="middle" rowspan="1" colspan="1">1571/2158</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lopez</td><td align="center" valign="middle" rowspan="1" colspan="1">2014</td><td align="center" valign="middle" rowspan="1" colspan="1">Panam&#x000e1;</td><td align="center" valign="middle" rowspan="1" colspan="1">50 at least</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">4125</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">25</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Alvarado</td><td align="center" valign="middle" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" rowspan="1" colspan="1">Honduras</td><td align="center" valign="middle" rowspan="1" colspan="1">50 at least</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">2999</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">26</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Campos</td><td align="center" valign="middle" rowspan="1" colspan="1">2011</td><td align="center" valign="middle" rowspan="1" colspan="1">Peru</td><td align="center" valign="middle" rowspan="1" colspan="1">50 at least</td><td align="center" valign="middle" rowspan="1" colspan="1">65.07</td><td align="center" valign="middle" rowspan="1" colspan="1">4849</td><td align="center" valign="middle" rowspan="1" colspan="1">2014/2835</td><td align="center" valign="middle" rowspan="1" colspan="1">38</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Duerksen</td><td align="center" valign="middle" rowspan="1" colspan="1">2011</td><td align="center" valign="middle" rowspan="1" colspan="1">Paraguay</td><td align="center" valign="middle" rowspan="1" colspan="1">50 at least</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">2862</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">21</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Barrenechea</td><td align="center" valign="middle" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" rowspan="1" colspan="1">Argentina</td><td align="center" valign="middle" rowspan="1" colspan="1">50 at least</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">3770</td><td align="center" valign="middle" rowspan="1" colspan="1">1691/2079</td><td align="center" valign="middle" rowspan="1" colspan="1">6</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">9</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lopez-Ramos</td><td align="center" valign="middle" rowspan="1" colspan="1">2014</td><td align="center" valign="middle" rowspan="1" colspan="1">Mexico</td><td align="center" valign="middle" rowspan="1" colspan="1">50 at least</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">5055</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">40</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" rowspan="1" colspan="1">8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Castellon</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Costa Rica</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">50 at least</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">64.64</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2493</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">923/1570</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">27</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">9</td></tr></tbody></table><table-wrap-foot><fn><p>M: male; F: female; NA: not applicable; N: number of patients.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="vision-09-00042-t002"><object-id pub-id-type="pii">vision-09-00042-t002_Table 2</object-id><label>Table 2</label><caption><p>Presents the definitions of glaucoma as outlined in each study.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Author</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Year</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Definition of Glaucoma</th></tr></thead><tbody><tr><td colspan="3" align="center" valign="middle" rowspan="1">Group 1</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Sakata</td><td align="center" valign="middle" rowspan="1" colspan="1">2003</td><td align="center" valign="middle" rowspan="1" colspan="1">Diagnosis required either: (1) optic disc abnormalities (VCDR &#x02265; 97.5th percentile in a hypernormal population) plus compatible VF defect; or (2) if VF could not be performed, a severely damaged optic disc (VCDR &#x02265; 99.5th percentile) alone was sufficient.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Povoa</td><td align="center" valign="middle" rowspan="1" colspan="1">1997</td><td align="center" valign="middle" rowspan="1" colspan="1">Referred to second phase if IOP &#x02265; 21 mmHg and/or at least one of the following: C/D ratio &#x02265; 0.5, disc asymmetry &#x02265; 0.2, localized rim thinning, papillary hemorrhage, or pallor. Diagnosis based on comprehensive ophthalmic assessment.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Mitchell</td><td align="center" valign="middle" rowspan="1" colspan="1">2008</td><td align="center" valign="middle" rowspan="1" colspan="1">Presumed glaucoma was diagnosed with IOP &#x0003e; 25 mmHg, disc abnormalities (as defined), and nerve fiber bundle loss.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Castellanos-Perilla</td><td align="center" valign="middle" rowspan="1" colspan="1">2015</td><td align="center" valign="middle" rowspan="1" colspan="1">Glaucoma status based on self-reported history of diagnosis.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Fernandes</td><td align="center" valign="middle" rowspan="1" colspan="1">2021</td><td align="center" valign="middle" rowspan="1" colspan="1">Diagnosis based on anterior segment biomicroscopy, lens status, IOP measurement, and dilated fundus examination.</td></tr><tr><td colspan="3" align="center" valign="middle" rowspan="1">Group 2</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Gallarreta</td><td align="center" valign="middle" rowspan="1" colspan="1">2011</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lopez</td><td align="center" valign="middle" rowspan="1" colspan="1">2014</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Alvarado</td><td align="center" valign="middle" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Campos</td><td align="center" valign="middle" rowspan="1" colspan="1">2011</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Duerksen</td><td align="center" valign="middle" rowspan="1" colspan="1">2011</td><td align="center" valign="middle" rowspan="1" colspan="1">Based on afferent pupil defect and corneal edema, VCDR &#x0003e; 0.8, or stone-hard eye on palpation.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Barrenechea</td><td align="center" valign="middle" rowspan="1" colspan="1">2013</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">Lopez-Ramos</td><td align="center" valign="middle" rowspan="1" colspan="1">2014</td><td align="center" valign="middle" rowspan="1" colspan="1">NA</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Castellon</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">NA</td></tr></tbody></table><table-wrap-foot><fn><p>NA: Not Available; IOP: Intraocular Pressure; VF: Visual Field; VCDR: Vertical Cup-to-Disc Ratio; C/D: Cup-to-Disc.</p></fn></table-wrap-foot></table-wrap></floats-group></article>